Navigation Links
NHS Choices Releases New Health A-Z Index
Date:2/7/2008

LONDON, February 7 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the online 'front door' for the NHS, has released an updated online information resource, Health A-Z, aimed to help people find facts on more than 700 conditions and treatments.

Based on NHS accredited information, the A-Z directory (http://www.nhs.uk/Conditions/Pages/bodymap.aspx) tells users all they need to know on a topic in seconds, providing them with clinically approved guidance so they can become experts.

"This directory has been created with users in mind and is a valuable addition to an ever growing armoury of health resources being made available to the public by the NHS Choices", said a spokesman. "It puts patients in the driving seat by giving them exactly the sort of reliable and dependable information they need to take control of their health at the click of a mouse".

Notes for Editors:

NHS Choices (http://www.nhs.uk ) is the online information service of the NHS that gives ordinary people the tools to make better, more informed choices about their treatments, health and wellbeing. It includes more than 80,000 pages of content, including video, interactive tools, a daily news service news and lifestyle features. Users can also check and compare hospital and doctors profiles and performance on-line.

For further information, please contact NHS Choices on: +44(0)207-972-1812


'/>"/>
SOURCE NHS Choices
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Grocery Shoppers Are Following Stars to More Nutritious Choices
2. FDA: Use the Nutrition Facts Label to Make Healthy Food Choices
3. ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices
4. New UIC center to study drug choices, safety
5. ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years
6. Video: New Web Site Helps Consumers and Employers Make Smart Choices on Health Savings Accounts (HSAs)
7. New choices for patients: Transfusion-free medicine for Jehovahs Witnesses and transfusion-wary
8. Everyday Choices Can Influence Cancer Risk
9. Lifestyle and cancer prevention: Making choices that change cancer risk
10. Congressman Tom Reynolds Awarded for Protecting Medicare Choices
11. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ent Highlights Women,s Unmet Needs for HIV Prevent...n Family Planning Methods , , (Para tener a...stellano, vaya al sitio www.preventionnow.net .) ...nternational coalition of organizations that repre...United States is demanding increased access to the...
(Date:12/1/2008)...HONORED FOR CAREER OF SCIENTIFIC DISCOVERY IN MOLE...RNewswire/ -- The Radiologic Society of North Amer... its "Outstanding Researcher of The Year" Award, r...has made original significant contributions to the...h. Dr. Weissleder is Professor at Harvard Medical...
(Date:12/1/2008)... Zimmer Holdings, Inc.,(...ry A. McCaulley has joined the,Company as Preside...ility for,the Company,s activities in the reconst...g and Americas Sales. Mr. McCaulley will report t...ef Executive Officer. , "Jeff has a tremend...
(Date:12/1/2008)...PRNewswire/ -- One of America,s leading plastic,s...aking technique for inner,vaginal lip reduction k...ective. His study is published in the December 20... the official medical journal of the American Soci...er lip) reduction or labioplasty,is the most comm...
Breaking Medicine News(10 mins):Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 2Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 3Health News:Plastic Surgery Journal Shows New Groundbreaking Genital Cosmetic Procedure for Women to be Successful 2
...out 10 percent of women in their mid-20s and about...Women with poor memory // skills are also often i...lements may reverse memory loss in these women. Re...en ages 18 and 35. The women were either anemic, i...
...ows calcium from milk, supplements, or other dairy...oting weight loss ,// so if your mother always tol...he may have been wrong. Participants in the stud...ight. Researchers say if the body consumes enough ...
...eatment plan for Leukemia , doctors rely on indica... to be, // including how the cancer cells look und...story. However, for some patients, those indicator...-risk or low-risk group. Doctors may be left guess...
... happens when a clot blocks blood flow to the brai...ction on their own. //Now, a new study shows patie...oke appear to regain more functional independence ...y, researchers evaluated the outcomes of 167 strok...
Other Medicine News:
(Date:11/26/2008)...n., Nov. 26 Children wh...ignificantly increased risk of developing mental i...f a Mayo Clinic study published this month in Ped...demy of Pediatrics. , , The retrospective s...with strabismus (misaligned eyes) and compared the...
(Date:11/25/2008)... most respondents against expanding statin use bro...TLE FALLS, N.J., Nov. 25 JUPITER, ... the cardiovascular risk of healthy patients with ...se in older adults, according to a national poll d...ipants took part in the online poll conducted by m...
(Date:11/25/2008).... 25 CardioVascular,Bio...ounced today that it has,dosed the first patient ...I,clinical trial to treat patients with severe co... the treatment of CORonary heart Disease) trial wi...-controlled doses in approximately 120,patients w...
(Date:11/24/2008)...rms its innovation leadership and long-term commit...N.J., Nov. 24 Schering-P...clinical update on boceprevir, its lead investigat...y in Phase III development. The company believes ...s and best-in-class protease inhibitor for treatin...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 1UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 2UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 3Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 1Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 2Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 3Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 4VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 1VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 2VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 3VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 4VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 5VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 6VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 7New research on sexual function 25566 1New research on sexual function 25566 2
...ndicate early non-responders unlikely to subsequen...ts, and may benefit,from earlier change in treatme...07 /PRNewswire-FirstCall/,-- New data presented at...Research (ICOSR) suggest that antipsychotic drug,r...ght, and,challenge the current schizophrenia treat...
... Reduced By an Average of More Than Two Hours Per .../PRNewswire/ --,Adding the once daily, investigati...our(TM) Extended-Release Tablets to,Parkinson,s pa...cantly reduced ,off, time, allowing patients to co...of time. ,Off time,describes the return of Parkin...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Used for percutaneous placement of a pigtail catheter in the renal pelvis for nephrostomy drainage. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is
The BioPlex 2200 system is a fully automated bead-based multiplexing immunoassay platform that can deliver up to 2200 results per hour. The system will initially include a panel of assays targeting a
Medicine Products: